THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,625,225 | -5.1% | 543,500 | -0.5% | 1.35% | -24.2% |
Q1 2023 | $5,927,398 | +503.1% | 546,304 | +523.6% | 1.78% | +419.0% |
Q4 2022 | $982,872 | -84.1% | 87,600 | -51.3% | 0.34% | -84.3% |
Q3 2017 | $6,163,000 | -14.1% | 180,000 | 0.0% | 2.18% | -27.2% |
Q2 2017 | $7,171,000 | +8.2% | 180,000 | 0.0% | 3.00% | -9.2% |
Q1 2017 | $6,627,000 | +31.4% | 180,000 | +13.8% | 3.30% | +11.0% |
Q4 2016 | $5,043,000 | – | 158,200 | – | 2.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |